The board meeting for Lucid Diagnostics Inc is scheduled for today, for the purpose of Lucid Diagnostics to Hold a Business Update Conference CallSee details
Lucid Diagnostics Inc has a share price target of US$ 4, revenue growth forecast of 96.3%, and profit growth estimate of 14.4% for FY25, based on top 6 analyst calls.